-
1.
公开(公告)号:EP3330267A1
公开(公告)日:2018-06-06
申请号:EP16830581.1
申请日:2016-07-28
申请人: Shionogi & Co., Ltd.
IPC分类号: C07D413/12 , A61K31/5377 , A61P35/00 , A61P43/00 , C07D265/30
CPC分类号: C07D413/12 , A61K31/5377 , C07B2200/13 , C07D265/30
摘要: Crystals of a quinazoline derivative are provided. The present invention relates to an acid addition salt of a compound represented by Formula (I):
a pharmaceutical composition containing it, and the like.-
公开(公告)号:EP3394042A1
公开(公告)日:2018-10-31
申请号:EP16826192.3
申请日:2016-12-22
申请人: Shionogi & Co., Ltd
发明人: ONODERA, Naohiro , NOGUCHI, Kouichi , ANDO, Shigeru , NAGAMATSU, Daiki , ISHIBASHI, Kenichi , OCHI, Shunsuke , HASEGAWA, Aiko , ODA, Katsuo
IPC分类号: C07D279/06 , C07D417/12
CPC分类号: C07D279/06 , C07D417/12
摘要: The present invention provides a process for preparation of the compound of formula (VI), wherein each symbol is as defined in the specification, without using any intermediate compound showing mutagenicity. The process comprises salt formation of the intermediate compound of formula (I) with acid to enable optical resolution to isolate the intermediate compound of formula (II) in a stereo-selective manner.
-